SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
51 hedge funds and large institutions have $127M invested in scPharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% less capital invested
Capital invested by funds: $129M → $127M (-$1.72M)
2.89% less ownership
Funds ownership: 65.46% → 62.57% (-2.9%)
Holders
51
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$277K | |
| 2 | +$196K | |
| 3 | +$175K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$133K |
| 5 |
Goldman Sachs
New York
|
+$123K |
Top Sellers
| 1 | -$1.35M | |
| 2 | -$621K | |
| 3 | -$605K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$399K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$284K |